Products Carteolol is available in the form of extended-release eye drops (Arteoptic LA). Carteolol has been approved in many countries since 1984. Arteopilo, the combination with pilocarpine, is no longer marketed in many countries. Structure and properties Carteolol (C16H24N2O3, Mr = 292.4 g/mol) is a dihydroquinolinone and a racemate. It is present in drugs as … Carteolol
Effects Beta-blockers (ATC S01ED) lower intraocular pressure. The effects are presumably due to a reduction in aqueous humor secretion. As with systemically administered agents, a distinction is made between selective and nonselective, hydrophilic and lipophilic, and agents with or without intrinsic sympathomimetic activity. Since the active substances can enter the bloodstream, they have the potential, … Beta Blocker Eye Drops
Symptoms Glaucoma is a progressive eye disease that is initially asymptomatic. Patients have no symptoms until the optic nerve becomes increasingly damaged, which can lead to irreversible visual impairment with visual field loss and blindness. Glaucoma represents the most common cause of blindness. Causes The cause of the disease is usually an increase in intraocular … Glaucoma: Causes and Treatment
Products Pilocarpine eye drops have been approved in many countries since 1960 (Spersacarpine). The combination with carteolol is off-label (Arteopilo). See also under pilocarpine tablets. Structure and properties Pilocarpine (C11H16N2O2, 208.26 g/mol) is present in the drops as pilocarpine hydrochloride, a white powder or colorless crystals that are very soluble in water. Pilocarpine is an … Pilocarpine Eye Drops
Products Betaxolol is commercially available in the form of eye drops (Betoptic S). It has been approved in many countries since 1995. Structure and properties Betaxolol is present in drugs as betaxolol hydrochloride and racemate (C18H30ClNO3, Mr = 343.9 g/mol), a white crystalline powder that is very soluble in water. The enantiomer levobetaxolol is also … Betaxolol
